158 related articles for article (PubMed ID: 33103262)
1. Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.
Xing S; Li Q; Xiong B; Chen Y; Feng F; Liu W; Sun H
Med Res Rev; 2021 Mar; 41(2):858-901. PubMed ID: 33103262
[TBL] [Abstract][Full Text] [Related]
2. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
5. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
6. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.
Xue L; Ko MC; Tong M; Yang W; Hou S; Fang L; Liu J; Zheng F; Woods JH; Tai HH; Zhan CG
Mol Pharmacol; 2011 Feb; 79(2):290-7. PubMed ID: 20971807
[TBL] [Abstract][Full Text] [Related]
7. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands.
Sun T; Zhen T; Harakandi CH; Wang L; Guo H; Chen Y; Sun H
Eur J Med Chem; 2024 Jun; 275():116569. PubMed ID: 38852337
[TBL] [Abstract][Full Text] [Related]
8. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine.
Xue L; Hou S; Tong M; Fang L; Chen X; Jin Z; Tai HH; Zheng F; Zhan CG
Biochem J; 2013 Aug; 453(3):447-54. PubMed ID: 23849058
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis.
Chen VP; Gao Y; Geng L; Brimijoin S
Int J Obes (Lond); 2017 Sep; 41(9):1413-1419. PubMed ID: 28529331
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
Jasiecki J; Wasąg B
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
[No Abstract] [Full Text] [Related]
12. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice.
Duysen EG; Li B; Carlson M; Li YF; Wieseler S; Hinrichs SH; Lockridge O
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):514-21. PubMed ID: 19067679
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.
Hamza A; Cho H; Tai HH; Zhan CG
J Phys Chem B; 2005 Mar; 109(10):4776-82. PubMed ID: 16851561
[TBL] [Abstract][Full Text] [Related]
14. Visualizing viral transduction of a cocaine-hydrolyzing, human butyrylcholinesterase in rats.
Gao Y; Brimijoin S
Chem Biol Interact; 2005 Dec; 157-158():97-103. PubMed ID: 16243302
[TBL] [Abstract][Full Text] [Related]
15. Computational redesign of human butyrylcholinesterase for anticocaine medication.
Pan Y; Gao D; Yang W; Cho H; Yang G; Tai HH; Zhan CG
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16656-61. PubMed ID: 16275916
[TBL] [Abstract][Full Text] [Related]
16. Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity.
Larrimore KE; Barcus M; Kannan L; Gao Y; Zhan CG; Brimijoin S; Mor T
Chem Biol Interact; 2013 Mar; 203(1):217-20. PubMed ID: 23000451
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool.
Ha ZY; Mathew S; Yeong KY
Curr Protein Pept Sci; 2020; 21(1):99-109. PubMed ID: 31702488
[TBL] [Abstract][Full Text] [Related]
19. Rational design of an enzyme mutant for anti-cocaine therapeutics.
Zheng F; Zhan CG
J Comput Aided Mol Des; 2008 Sep; 22(9):661-71. PubMed ID: 17989928
[TBL] [Abstract][Full Text] [Related]
20. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses.
Lockridge O
Pharmacol Ther; 2015 Apr; 148():34-46. PubMed ID: 25448037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
